HomeNeuroscienceTourette wearable device 'changes lives'

Tourette wearable device 'changes lives'

A wrist device developed by researchers in Nottingham, England, has shown dramatic improvements in people with Tourette syndrome and is now awaiting regulatory approval in Britain, reports the BBC.

Tourette’s is a neurodevelopmental condition with symptoms usually starting in childhood.

One of the sufferers is Katie (15), whose tics were so relentless when she was a child that they left her bedridden with a sore throat for two weeks. The syndrome affected her ability to sleep and eat, and caused her to miss school, but the wrist device helped her calm down in an “instant”, she said.

Katie recalled trying on the device for the first time, and said: “It was absolutely life-changing… the best day ever.”

She was among the first people to use the Neupulse device – developed by the University of Nottingham – which works by delivering electrical pulses to the median nerve at the wrist, and which trials have shown can change the activity in the parts of the brain involved in movement control.

The developers found that rhythmic stimulation can reduce the frequency and intensity of tics.

In 2023, a clinical trial of 121 people found they experienced, on average, a reduction in tic frequency of 25% while using a prototype of the device.

The device was developed by the university and its spin-out company Neurotherapuetics Ltd, which secured £1m in additional funding to commercialise it.

The Tourette’s Action charity said there are two versions of the device: Neupulse-C – available as a consumer wellness device – and Neupulse-M, which is intended to be marketed as a medical device specifically for the treatment of tics and Tourette syndrome, but which has not yet received regulatory approval for this purpose.

Neupulse-M is still going through the regulatory approval process. It is hoped that when approval is obtained, the device will be considered for NHS use.

The charity added that the National Institute for Health and Care Excellence (NICE) had identified the technology as “promising”, and had requested further evidence of its long-term benefits before making recommendations over NHS adoption.

The university said “thousands” of the devices had been sold so far.

Professor Stephen Jackson, who has led the research, said seeing the impact on users of the device had been “a dream come true”, and hoped it would be available on the NHS “in the next year or so”.

“We are working as hard as we can to get regulatory approval for the Neupulse device as a treatment for Tourette syndrome. It’s been provisionally evaluated by NICE, but they were unable to recommend it for use in the NHS until we have the regulatory approval. We’re working towards that.”

Tourette’s Action says more than 300 000 people in the UK have the condition, which is incurable.

The Neupulse-C is currently on sale as a wellness device.

The device has recently been tested in early trials for people with Parkinson’s to see if it can be used to reduce tremors.

Jackson said the university was also considering a UK-wide clinical trial to look at both anxiety and obsessive-compulsive disorder (OCD).

 

BBC News article – Trying Tourette's device was the best day of my life (Open access)

 

See more from MedicalBrief archives:

 

Median nerve stimulation gives treatment hope for Tourette Syndrome

 

Deep brain stimulation helps treat Tourette syndrome adolescents

 

Tourettes Charity wants comedian to apologise for award-winning joke

MedicalBrief — our free weekly e-newsletter

We'd appreciate as much information as possible, however only an email address is required.